Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation

Abstract

Oseltamivir is well tolerated and may reduce mortality of influenza virus-infected patients after HSCT. PCR may help to optimize diagnosis and to monitor treatment strategies.